01 1Belmore Neidrauer LLP
02 2Blake Cassels & Graydon LLP
03 7Gilead Sciences Canada Inc.
04 14GlaxoSmithKline Inc.
01 12104399
02 12105486
03 12261619
04 12298059
05 42398887
06 42452217
07 12537095
08 12577288
09 22606282
10 22636436
11 22654115
12 22810524
13 23060290
01 14CABOTEGRAVIR | RILPIVIRINE
02 3Rilpivirine hydrochloride
03 7tenofovir disoproxil fumarate | emtricitabine | rilpivirine
01 14SUSPENSION (EXTENDED-RELEASE)
02 3Tablet
03 7Tablets
01 12012-02-20
02 12012-03-05
03 12017-07-25
04 12018-07-23
05 42021-02-26
06 42022-08-09
07 12024-09-03
08 12025-09-02
09 22026-04-28
10 22027-01-19
11 22027-06-22
12 22031-01-24
13 22031-09-15
Patent Expiration Date : 2024-09-03
Date Granted : 2012-05-29
tenofovir disoproxil fumarate, emtricitabine, rilpivirine
Brand Name : COMPLERA
Patent Number : 2537095
Filing Date : 2004-09-03
Strength per Unit : 300mg / 200mg / 25mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-09-03
Date Granted : 2012-05-29
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
tenofovir disoproxil fumarate, emtricitabine, rilpivirine
Brand Name : COMPLERA
Patent Number : 2398887
Filing Date : 2001-02-26
Strength per Unit : 300mg / 200mg / 25mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
tenofovir disoproxil fumarate, emtricitabine, rilpivirine
Brand Name : COMPLERA
Patent Number : 2261619
Filing Date : 1997-07-25
Strength per Unit : 300mg / 200mg / 25mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Patent Expiration Date : 2012-03-05
Date Granted : 2003-10-28
tenofovir disoproxil fumarate, emtricitabine, rilpivirine
Brand Name : COMPLERA
Patent Number : 2105486
Filing Date : 1992-03-05
Strength per Unit : 300mg / 200mg / 25mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-03-05
Date Granted : 2003-10-28
Patent Expiration Date : 2012-02-20
Date Granted : 2005-10-18
tenofovir disoproxil fumarate, emtricitabine, rilpivirine
Brand Name : COMPLERA
Patent Number : 2104399
Filing Date : 1992-02-20
Strength per Unit : 300mg / 200mg / 25mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-02-20
Date Granted : 2005-10-18
Patent Expiration Date : 2022-08-09
Date Granted : 2009-06-16
tenofovir disoproxil fumarate, emtricitabine, rilpivirine
Brand Name : COMPLERA
Patent Number : 2452217
Filing Date : 2002-08-09
Strength per Unit : 300mg / 200mg / 25mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-08-09
Date Granted : 2009-06-16
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
tenofovir disoproxil fumarate, emtricitabine, rilpivirine
Brand Name : COMPLERA
Patent Number : 2298059
Filing Date : 1998-07-23
Strength per Unit : 300mg / 200mg / 25mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Patent Expiration Date : 2025-09-02
Date Granted : 2010-11-30
Brand Name : EDURANT
Patent Number : 2577288
Filing Date : 2005-09-02
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-09-02
Date Granted : 2010-11-30
Patent Expiration Date : 2022-08-09
Date Granted : 2009-06-16
Brand Name : EDURANT
Patent Number : 2452217
Filing Date : 2002-08-09
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-08-09
Date Granted : 2009-06-16
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
Brand Name : EDURANT
Patent Number : 2398887
Filing Date : 2001-02-26
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
